Shire/Noven Daytrana Patch To Carry Similar Warnings To Other ADHD Drugs, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The transdermal methylphenidate patch is approved with one additional warning relating to skin reactions and possible sensitivity to oral methylphenidate products.
You may also be interested in...
Shire Voluntarily Withdraws Daytrana Patches After Enhancing Adhesive
Firm’s decision comes after patients and caregivers experienced difficulty removing the release liner from some Daytrana patches.
Shire Voluntarily Withdraws Daytrana Patches After Enhancing Adhesive
Firm’s decision comes after patients and caregivers experienced difficulty removing the release liner from some Daytrana patches.
A Sticky Situation For Shire’s Daytrana Patch, ISMP Reports
Shire will address adhesion issue following complaints that the adhesive for the patches sticks to the protective lining.